MITF and melanoma: As a result, melanoma cells expressing low levels of MITF and high BRN2 (MITFlow/BRN2high) are demonstrated to be significantly more tumorigenic than MITFhigh/BRN2low cells when injected subcutaneously into mice (Goodall et al., 2008).